Routine Health Screening Market Outlook 2026–2030 Exploring New Business Opportunities
The Business Research Company’s 2026 market reports include new capabilities such as market attractiveness scoring and analysis, total addressable market analysis, company scoring matrix, interactive excel data dashboard, improved supply chain analysis, upcoming startups in the market, and overview of key products, aimed at improving the depth, usability, and strategic value of the insights delivered.
What Is The Expected Market Size Of The Routine Health Screening Market From 2026 To 2030?
The routine health screening market size has demonstrated strong expansion in recent years. It is anticipated to increase from $58.45 billion in 2025 to $62.9 billion in 2026, registering a compound annual growth rate (CAGR) of 7.6%. The drivers behind this historical growth include heightened public health awareness, the broader reach of diagnostic laboratory networks, a greater prevalence of chronic diseases, better access to fundamental healthcare services, and the rise of employer-sponsored health screening programs.
The routine health screening market size is projected to experience robust growth in the upcoming years. It is anticipated to expand to $83.35 billion by 2030, achieving a compound annual growth rate (CAGR) of 7.3%. The expansion within this forecast period is attributable to the increasing embrace of personalized preventive care, a growing need for remote and home-based diagnostics, the broadening of digital health platforms, a rise in the use of advanced screening technologies, and an elevated focus on population health management. Key trends during this period include the increased adoption of preventive health screening programs, the expanding utilization of home-based diagnostic testing, broader integration of digital health records, a heightened focus on early disease detection, and improved accessibility of routine screening services.
Download the Free Sample Report to Explore Key Market Insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=20618&type=smp
What Drivers Are Influencing The Routine Health Screening Market?
The expanding understanding of preventive healthcare is anticipated to drive the future expansion of the routine health screenings market. Preventive healthcare encompasses strategies and actions focused on averting the development or worsening of illnesses and health issues via early identification, changes in lifestyle, and proactive measures. The heightened recognition of preventive healthcare stems from its advantages in prompt disease detection, enhanced health results, and financial efficiencies, fueled by advancements in public education and medical science. Routine health screenings support preventive healthcare by uncovering potential health problems at an early stage, enabling prompt actions, and lowering the likelihood of serious illnesses. For example, data from May 2023, provided by the National Health Service (NHS), a publicly funded healthcare system based in the UK, indicated that 2,302,400 diagnostic tests were performed in March 2023, representing a rise of 223,100 tests from March 2022. By the close of March 2023, the count of patients awaiting a crucial diagnostic test reached 1,628,300, which was an increase of 59,400 when contrasted with March 2022. Consequently, the growing understanding of preventive healthcare is propelling the expansion of the routine health screenings market.
Which Segments Are Included In The Analysis Of The Routine Health Screening Market?
The routine health screening market covered in this report is segmented –
1) By Test Type: Blood Glucose Test, Kidney Function Test, Bone Profile Test, Electrolyte Test, Liver Function Test, Lipid Profile Test, Other Test Types
2) By Sample Type: Blood, Urine, Serum, Saliva, Other Sample Types
3) By Technology: Quantitative Polymerase Chain Reaction (QPCR), Quantitative Fluorescence In Situ Hybridization (Q-FISH), Immunoassays, Medical Imaging, Single Telomere Length Analysis (STELA), Other Technologies
4) By Sample Collection Sites: Hospitals, Homes, Diagnostic Laboratories, Offices, Other Sample Collection Sites
Subsegments:
1) By Blood Glucose Test: Fasting Blood Glucose Test, HbA1c Test, Continuous Glucose Monitoring
2) By Kidney Function Test: Serum Creatinine Test, Blood Urea Nitrogen (BUN) Test, Urinalysis
3) By Bone Profile Test: Serum Calcium Test, Phosphate Test, Bone Mineral Density (BMD) Test
4) By Electrolyte Test: Serum Sodium Test, Serum Potassium Test, Serum Chloride Test
5) By Liver Function Test: Alanine Aminotransferase (ALT) Test, Aspartate Aminotransferase (AST) Test, Bilirubin Test
6) By Lipid Profile Test: Total Cholesterol Test, Low-Density Lipoprotein (LDL) Test, High-Density Lipoprotein (HDL) Test
7) By Other Test Types: Thyroid Function Test, Complete Blood Count (CBC), Prostate-Specific Antigen (PSA) Test
What Trends Are Affecting The Expansion Of The Routine Health Screening Market?
Leading companies in the routine health screenings market are concentrating on developing advanced solutions, such as lung cancer screening tests, to achieve a competitive edge. Lung cancer screening tests are medical evaluations designed to identify lung cancer at an early stage in individuals at high risk, even before symptoms emerge. For instance, in October 2023, DELFI Diagnostics Inc., a US-based diagnostic technology company, launched FirstLook Lung, an innovative blood test engineered to improve lung cancer screening. Utilizing fragmentomics, FirstLook Lung analyzes patterns in cell-free DNA (cfDNA) from blood samples and employs advanced machine learning to differentiate between cancerous and non-cancerous patterns. With a 99.7% negative predictive value (NPV), the test effectively detects potential lung cancer cases while minimizing the need for unnecessary low-dose CT (LDCT) scans. Integrated into routine blood tests, FirstLook Lung aims to enhance screening rates, particularly among underserved groups, and features a scalable whole-genome machine-learning platform with the potential for global expansion into other cancers and treatment monitoring.
Which Key Industry Participants Are Active In The Routine Health Screening Market?
Major companies operating in the routine health screening market are Roche Holding AG, Thermo Fisher Scientific Inc., Siemens Healthineers, Laboratory Corporation, Quest Diagnostics Incorporated, Eurofins Scientific SE, Agilent Technologies Inc., Sonic Healthcare Limited, Hologic Inc., Illumina Inc., SYNLAB International GmbH, Sysmex Corporation, QIAGEN N.V., Exact Sciences Corporation, RadNet Inc., Opko Health Inc., UNILABS, Amedes Holding GmbH, Natera Inc., Grail Inc., Trinity Biotech PLC, Cerba HealthCare S.A.S., Quidel Corporation, Innova Medical Group
Read the full routine health screening market report here:
https://www.thebusinessresearchcompany.com/report/routine-health-screening-global-market-report
Which Regions Are Expected To Experience Rapid Expansion In The Routine Health Screening Market?
North America was the largest region in the routine health screening market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the routine health screening market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Request A Tailored Routine Health Screening Market Research Report For Competitive Advantage:
https://www.thebusinessresearchcompany.com/customise?id=20618&type=smp
Browse Through More Reports Similar to the Global Routine Health Screening Market 2026, By The Business Research Company
Connected Healthcare Global Market Report
https://www.thebusinessresearchcompany.com/report/connected-healthcare-global-market-report
Consumer Healthcare Global Market Report
https://www.thebusinessresearchcompany.com/report/consumer-healthcare-global-market-report
Poultry Healthcare Global Market Report
https://www.thebusinessresearchcompany.com/report/poultry-healthcare-global-market-report
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 310-496-7795
Asia +44 7882 955267 & +91 8897263534
Europe +44 7882 955267
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
